Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo.

Barrett BS, Smith DS, Li SX, Guo K, Hasenkrug KJ, Santiago ML.

PLoS Pathog. 2012;8(3):e1002596. doi: 10.1371/journal.ppat.1002596. Epub 2012 Mar 22.

PMID:
22457621
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.

Harper MS, Barrett BS, Smith DS, Li SX, Gibbert K, Dittmer U, Hasenkrug KJ, Santiago ML.

J Immunol. 2013 Feb 15;190(4):1583-90. doi: 10.4049/jimmunol.1202920. Epub 2013 Jan 11.

PMID:
23315078
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Tetherin Promotes the Innate and Adaptive Cell-Mediated Immune Response against Retrovirus Infection In Vivo.

Li SX, Barrett BS, Heilman KJ, Messer RJ, Liberatore RA, Bieniasz PD, Kassiotis G, Hasenkrug KJ, Santiago ML.

J Immunol. 2014 Jul 1;193(1):306-16. doi: 10.4049/jimmunol.1400490. Epub 2014 May 28.

PMID:
24872193
[PubMed - in process]
4.

Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo.

Liberatore RA, Bieniasz PD.

Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18097-101. doi: 10.1073/pnas.1113694108. Epub 2011 Oct 24.

PMID:
22025715
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.

Lopez LA, Yang SJ, Hauser H, Exline CM, Haworth KG, Oldenburg J, Cannon PM.

J Virol. 2010 Jul;84(14):7243-55. doi: 10.1128/JVI.02636-09. Epub 2010 May 5.

PMID:
20444895
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.

Tsuji-Kawahara S, Chikaishi T, Takeda E, Kato M, Kinoshita S, Kajiwara E, Takamura S, Miyazawa M.

J Virol. 2010 Jun;84(12):6082-95. doi: 10.1128/JVI.02516-09. Epub 2010 Apr 7.

PMID:
20375169
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.

Smith DS, Guo K, Barrett BS, Heilman KJ, Evans LH, Hasenkrug KJ, Greene WC, Santiago ML.

PLoS Pathog. 2011 Oct;7(10):e1002284. doi: 10.1371/journal.ppat.1002284. Epub 2011 Oct 6.

PMID:
21998583
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.

Santiago ML, Benitez RL, Montano M, Hasenkrug KJ, Greene WC.

J Immunol. 2010 Jul 15;185(2):1114-23. doi: 10.4049/jimmunol.1001143. Epub 2010 Jun 21.

PMID:
20566830
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons.

Sarojini S, Theofanis T, Reiss CS.

DNA Cell Biol. 2011 Dec;30(12):965-74. doi: 10.1089/dna.2011.1384. Epub 2011 Sep 15.

PMID:
21919738
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT.

PLoS Pathog. 2009 May;5(5):e1000429. doi: 10.1371/journal.ppat.1000429. Epub 2009 May 15.

PMID:
19436700
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Tetherin restricts productive HIV-1 cell-to-cell transmission.

Casartelli N, Sourisseau M, Feldmann J, Guivel-Benhassine F, Mallet A, Marcelin AG, Guatelli J, Schwartz O.

PLoS Pathog. 2010 Jun 17;6(6):e1000955. doi: 10.1371/journal.ppat.1000955.

PMID:
20585562
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.

Zelinskyy G, Balkow S, Schimmer S, Schepers K, Simon MM, Dittmer U.

Virology. 2004 Dec 20;330(2):365-74.

PMID:
15567431
[PubMed - indexed for MEDLINE]
Free Article
13.

Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.

Santiago ML, Montano M, Benitez R, Messer RJ, Yonemoto W, Chesebro B, Hasenkrug KJ, Greene WC.

Science. 2008 Sep 5;321(5894):1343-6. doi: 10.1126/science.1161121.

PMID:
18772436
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Influenza virus partially counteracts restriction imposed by tetherin/BST-2.

Mangeat B, Cavagliotti L, Lehmann M, Gers-Huber G, Kaur I, Thomas Y, Kaiser L, Piguet V.

J Biol Chem. 2012 Jun 22;287(26):22015-29. doi: 10.1074/jbc.M111.319996. Epub 2012 Apr 6.

PMID:
22493439
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD.

Cell. 2009 Oct 30;139(3):499-511. doi: 10.1016/j.cell.2009.08.039.

PMID:
19879838
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.

Santiago ML, Smith DS, Barrett BS, Montano M, Benitez RL, Pelanda R, Hasenkrug KJ, Greene WC.

J Virol. 2011 Jan;85(1):189-99. doi: 10.1128/JVI.01838-10. Epub 2010 Oct 27.

PMID:
20980520
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.

Miyakawa K, Ryo A, Murakami T, Ohba K, Yamaoka S, Fukuda M, Guatelli J, Yamamoto N.

PLoS Pathog. 2009 Dec;5(12):e1000700. doi: 10.1371/journal.ppat.1000700. Epub 2009 Dec 18.

PMID:
20019814
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.

McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJ, Bieniasz PD.

PLoS Pathog. 2009 Feb;5(2):e1000300. doi: 10.1371/journal.ppat.1000300. Epub 2009 Feb 13.

PMID:
19214216
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.

Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM.

Retrovirology. 2010 Jun 7;7:51. doi: 10.1186/1742-4690-7-51. Erratum in: Retrovirology. 2011;8:85.

PMID:
20529266
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.

Schindler M, Rajan D, Banning C, Wimmer P, Koppensteiner H, Iwanski A, Specht A, Sauter D, Dobner T, Kirchhoff F.

Retrovirology. 2010 Jan 15;7:1. doi: 10.1186/1742-4690-7-1.

PMID:
20078884
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk